Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alfredo Berruti

Showing results (121-130 of 380) with videos related to

Pageof 38
Sort By:
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 17, 2018
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcomaSalvatore Grisanti, Deborah Cosentini, Valeria Tovazzi, et al.
Future Oncology (London, England)|August 29, 2020
The long and winding road to effective immunotherapy in patients with adrenocortical carcinomaSalvatore Grisanti, Deborah Cosentini, Marta Laganà, et al.
Anticancer Research|August 28, 2004
A phase II trial of weekly paclitaxel and gemcitabine in non-small cell lung cancer patients previously treated with platinum and vinorelbineVincenzo Dongiovanni, Alfredo Addeo, Alfredo Berruti, et al.
Endocrine-Related Cancer|December 15, 2016
Regression of advanced neuroendocrine tumors among patients receiving placeboVito Amoroso, Giorgio Maria Agazzi, Elisa Roca, et al.
La Radiologia Medica|June 8, 2019
Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapyMarco Ravanelli, Giorgio Maria Agazzi, Elena Tononcelli, et al.
Frontiers in Oncology|June 15, 2026
Overcoming absolute dysphagia in a thirty-year-old patient with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: a case reportLuca Carlofrancesco Ammoni, Giorgia Carola, Giuseppe Ippolito, et al.
Annals of Surgical Oncology|October 28, 2022
Mitotane With or Without Cisplatin and Etoposide for Patients with a High Risk of Recurrence in Stages 1-3 Adrenocortical Cancer After SurgeryAmber Leila Sarvestani, Stephanie N Gregory, Martha E Teke, et al.
Frontiers in Endocrinology|May 10, 2021
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical CarcinomaDeborah Cosentini, Antonella Turla, Ornella Carminati, et al.
Human Pathology|October 17, 2015
Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation casesEleonora Duregon, Marco Volante, Enrico Bollito, et al.
Endocrine|October 12, 2017
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinomaMélanie Claps, Sara Cerri, Salvatore Grisanti, et al.
Pageof 38

Showing results (121-130 of 380) with videos related to

Sort By:
Pageof 38
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 17, 2018
Hepatoprotective effect of N-acetylcysteine in trabectedin-induced liver toxicity in patients with advanced soft tissue sarcomaSalvatore Grisanti, Deborah Cosentini, Valeria Tovazzi, et al.
Future Oncology (London, England)|August 29, 2020
The long and winding road to effective immunotherapy in patients with adrenocortical carcinomaSalvatore Grisanti, Deborah Cosentini, Marta Laganà, et al.
Anticancer Research|August 28, 2004
A phase II trial of weekly paclitaxel and gemcitabine in non-small cell lung cancer patients previously treated with platinum and vinorelbineVincenzo Dongiovanni, Alfredo Addeo, Alfredo Berruti, et al.
Endocrine-Related Cancer|December 15, 2016
Regression of advanced neuroendocrine tumors among patients receiving placeboVito Amoroso, Giorgio Maria Agazzi, Elisa Roca, et al.
La Radiologia Medica|June 8, 2019
Texture features of colorectal liver metastases on pretreatment contrast-enhanced CT may predict response and prognosis in patients treated with bevacizumab-containing chemotherapy: a pilot study including comparison with standard chemotherapyMarco Ravanelli, Giorgio Maria Agazzi, Elena Tononcelli, et al.
Frontiers in Oncology|June 15, 2026
Overcoming absolute dysphagia in a thirty-year-old patient with advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: a case reportLuca Carlofrancesco Ammoni, Giorgia Carola, Giuseppe Ippolito, et al.
Annals of Surgical Oncology|October 28, 2022
Mitotane With or Without Cisplatin and Etoposide for Patients with a High Risk of Recurrence in Stages 1-3 Adrenocortical Cancer After SurgeryAmber Leila Sarvestani, Stephanie N Gregory, Martha E Teke, et al.
Frontiers in Endocrinology|May 10, 2021
Case Report: Exceptional Response to Second Line Temozolomide Therapy in a Patient With Metastatic Adrenocortical CarcinomaDeborah Cosentini, Antonella Turla, Ornella Carminati, et al.
Human Pathology|October 17, 2015
Pitfalls in the diagnosis of adrenocortical tumors: a lesson from 300 consultation casesEleonora Duregon, Marco Volante, Enrico Bollito, et al.
Endocrine|October 12, 2017
Adding metyrapone to chemotherapy plus mitotane for Cushing's syndrome due to advanced adrenocortical carcinomaMélanie Claps, Sara Cerri, Salvatore Grisanti, et al.
Pageof 38